Derek K. Ng

Optometry

4450 E Sam Houston Pkwy S
Suite E
Pasadena, TX 77505

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 129 publications

The Congenital Heart Disease in Children: Kidney-Associated Conditions with Epidemiologic Endpoints (CHICKADEE) study: Study design and protocol.

The Congenital Heart Disease in Children: Kidney-Associated Conditions with Epidemiologic Endpoints (CHICKADEE) study: Study design and protocol.

Journal: PloS one

Published: July 22, 2026

Limitations in the Use of Plasma Biomarkers of Brain Injury-Reply.

Limitations in the Use of Plasma Biomarkers of Brain Injury-Reply.

Journal: JAMA pediatrics

Published: July 13, 2026

Patterns of Multiple Organ Dysfunction in Children on Extracorporeal Membrane Oxygenation Support.

Patterns of Multiple Organ Dysfunction in Children on Extracorporeal Membrane Oxygenation Support.

Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)

Published: June 16, 2026

Response to Xu, Hu and Ruan (2026) Comment on "The epidemiology of kidney and urinary tract infections in pediatric chronic kidney disease: prevalence, risk factors and association with GFR decline in the chronic kidney disease in children study".

Response to Xu, Hu and Ruan (2026) Comment on "The epidemiology of kidney and urinary tract infections in pediatric chronic kidney disease: prevalence, risk factors and association with GFR decline in the chronic kidney disease in children study".

Journal: Pediatric nephrology (Berlin, Germany)

Published: May 27, 2026

An Introduction to Competing Risks in Epidemiology [Letter].

An Introduction to Competing Risks in Epidemiology [Letter].

Journal: Clinical epidemiology

Published: March 03, 2026

Plasma Biomarkers of Brain Injury in Critically Ill Children Receiving Extracorporeal Membrane Oxygenation.

Plasma Biomarkers of Brain Injury in Critically Ill Children Receiving Extracorporeal Membrane Oxygenation.

Journal: JAMA pediatrics

Published: March 02, 2026

Association of N-Terminal Pro-Brain Natriuretic Peptide With CKD Progression in the CKD in Children Study.

Association of N-Terminal Pro-Brain Natriuretic Peptide With CKD Progression in the CKD in Children Study.

Journal: Kidney medicine

Published: January 09, 2026

The epidemiology of kidney and urinary tract infections in pediatric chronic kidney disease: prevalence, risk factors and association with GFR decline in the Chronic Kidney Disease in Children Study.

The epidemiology of kidney and urinary tract infections in pediatric chronic kidney disease: prevalence, risk factors and association with GFR decline in the Chronic Kidney Disease in Children Study.

Journal: Pediatric nephrology (Berlin, Germany)

Published: October 24, 2025

Insurance Network Status and 1-Year Health Care Utilization and Outpatient Costs Among Commercially Insured Patients With Newly Diagnosed and Non-Definitively Treated Prostate Cancer, 2010-2021.

Insurance Network Status and 1-Year Health Care Utilization and Outpatient Costs Among Commercially Insured Patients With Newly Diagnosed and Non-Definitively Treated Prostate Cancer, 2010-2021.

Journal: Cancer medicine

Published: October 02, 2025

Fibroblast Growth Factor 23 Trajectories in Children and Association with CKD Progression: The CKD in Children Study.

Fibroblast Growth Factor 23 Trajectories in Children and Association with CKD Progression: The CKD in Children Study.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: August 20, 2025

FGF23 Trajectories in Children and Association with CKD Progression: The Chronic Kidney Disease in Children Study.

FGF23 Trajectories in Children and Association with CKD Progression: The Chronic Kidney Disease in Children Study.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: August 20, 2025

Effectiveness of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy on Risk of Death for Individuals With Cystic Fibrosis.

Effectiveness of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy on Risk of Death for Individuals With Cystic Fibrosis.

Journal: Chest

Published: July 29, 2025

Showing 1-12 of 129

Last Updated: 09/26/2026